This episode currently has no reviews.
Submit Reviewintelligence-apple-execs-explain-why-its-ai-is-different.html">Apple has entered the AI arms race. WSJ personal tech columnist Joanna Stern discusses the OpenAI-Siri integration, Genmoji, privacy, and musk-to-ban-apple-devices-from-his-companies-over-openai-deal.html">Elon Musk’s reaction to Apple’s announcements at the company’s wwdc-live-updates.html">Worldwide Developers Conference. In the wake of EU elections and a shift to the political right across the bloc, Council on Foreign Relations president emeritus Richard Haass considers implications for US politics. He says it’s a tough time for incumbents, and it’s an uncertain world for whoever wins in the upcoming election. Plus, former media executive Edgar Bronfman is reportedly considering a bid for Paramount’s parent company, CNBC’s Emily Wilkins reports on the bipartisan support to crack down on hotel junk fees, and an FDA advisory panel has endorsed Eli Lilly’s Alzheimer’s drug.
Richard Haass - 13:29
Joanna Stern - 22:23
In this episode:
Joanna Stern, @JoannaStern
Emily Wilkins, @emrwilkins
Joe Kernen, @JoeSquawk
Becky Quick,@BeckyQuick
Andrew Ross Sorkin,@andrewrsorkin
Katie Kramer,@Kramer_Katie
intelligence-apple-execs-explain-why-its-ai-is-different.html">Apple has entered the AI arms race. WSJ personal tech columnist Joanna Stern discusses the OpenAI-Siri integration, Genmoji, privacy, and musk-to-ban-apple-devices-from-his-companies-over-openai-deal.html">Elon Musk’s reaction to Apple’s announcements at the company’s wwdc-live-updates.html">Worldwide Developers Conference. In the wake of EU elections and a shift to the political right across the bloc, Council on Foreign Relations president emeritus Richard Haass considers implications for US politics. He says it’s a tough time for incumbents, and it’s an uncertain world for whoever wins in the upcoming election. Plus, former media executive Edgar Bronfman is reportedly considering a bid for Paramount’s parent company, CNBC’s Emily Wilkins reports on the bipartisan support to crack down on hotel junk fees, and an FDA advisory panel has endorsed Eli Lilly’s Alzheimer’s drug.
Richard Haass - 13:29
Joanna Stern - 22:23
In this episode:
Joanna Stern, @JoannaStern
Emily Wilkins, @emrwilkins
Joe Kernen, @JoeSquawk
Becky Quick,@BeckyQuick
Andrew Ross Sorkin,@andrewrsorkin
Katie Kramer,@Kramer_Katie
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review